Effect of Ozoralizumab Administration with or without Methotrexate in Patients with Rheumatoid Arthritis: A Post-Hoc Analysis

Effect of Ozoralizumab Administration with or without Methotrexate in Patients with Rheumatoid Arthritis: A Post-Hoc Analysis

Abstract Introduction Ozoralizumab (OZR) is a novel tumor necrosis factor (TNF) inhibitor that was launched in Japan for treating patients with rheumatoid arthritis (RA) who have had an inadequate response to existing therapies. This post-hoc analysis aimed to compare the efficacy of OZR administere...

Full description

Saved in:
Bibliographic Details
Main Authors: Yoshiya Tanaka, Nobuko Horiuchi, Cosmo Sasajima, Rumiko Matsumoto, Masafumi Kawanishi, Saeko Uchida, Tsutomu Takeuchi
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-01-01
Series:Rheumatology and Therapy
Subjects:
Antitumor necrosis factor inhibitor
Combination with methotrexate
Ozoralizumab
Propensity score matching
Rheumatoid arthritis
Online Access:https://doi.org/10.1007/s40744-024-00737-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40744-024-00737-3

Similar Items